Our website is made possible by displaying non-intrusive online advertisements to our visitors.
Please consider supporting us by disabling or pausing your ad blocker.
Comparing to its competitor, YSPSAH, Adventa is over-valued. just look at their current price / NTA ratio. Simply put, cut loss now and buy back at 40 sen